about
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradationInsulin-degrading enzyme does not require peroxisomal localization for insulin degradationMolecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading EnzymeCELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation
P921
Q1225690-E5D90691-D6D2-45ED-840E-A330F1E9D57DQ21171950-0FF40F89-C018-41C6-ACC3-32AE8D812DE6Q21499241-7F76BF83-612C-4B66-AADA-47CD65B1BD80Q28557389-89471560-662E-4E14-B70A-880E4F5A53A1Q28562356-4412F9AD-EE93-4B69-A6EA-05A01C321A8EQ28562356-93B4E187-4799-4F8A-ADE8-D3FBE4E338A3Q29816454-E00E60B9-C9CE-493C-A6D9-B5E3B2B8672D
P682
description
The chemical reactions and pathways resulting in the breakdown of insulin.
@en
biologisch proces
@nl
name
insulin catabolic process
@en
type
label
insulin catabolic process
@en
altLabel
GO:1901143
@en
insulin breakdown
@en
insulin catabolism
@en
insulin degradation
@en
prefLabel
insulin catabolic process
@en
P2888
P686
GO:1901143